Inside Innovation

Marc Cummings, CEO of Life Science Washington, took the stage at Life Science Innovation Northwest 2022 to share his expertise in a live interview with

This year’s Life Science Washington Innovation Northwest conference brought hundreds of researchers and entrepreneurs together over two days to discuss a wide range of science

At Life Science Washington’s annual conference, Life Science Innovation Northwest, industry veterans Hans Bishop and Steve Harr shared their expertise on building companies and discussed

Seagen announced it is building a 270,000-square-foot facility in Everett, Washington to bolster its drug manufacturing capabilities. Slated to open in 2024 just north of

BioMed Realty paid nearly $127 million for a downtown Seattle block where they seek to develop 1.2 million square feet of life science and technology

Seattle-based biotech non-profit, Access to Advanced Health Institute (AAHI) announced a $26 million donation from the Chan Soon-Shiong Family Foundation (CSSFF). The donation will be

Aurion Biotech, a spinoff of Seattle eye care company, CorneaGen, has received $120 million in funding to help advance cell therapy for corneal endothelial dystrophies,

New research by Blind, a social network for employees in tech and other industries, shows that Washington state ranks top of the list for cities

With 20 percent of the national workforce working remotely, a recent report by Wallethub reveals that Washington is the eighth-best state to work from home.

In a Q&A interview conducted by GeekWire reporter, Charlotte Schubert, Rui Costa, the Allen Institute’s new CEO, talks about his vision for his new role,

Seattle has been named the seventh happiest city in the nation in a new report by WalletHub. The report analyzed indicators across 180 cities and

Receptor Life Sciences, a Seattle-based startup, announced it has raised $9.7 million in a Series A-1 funding round to push its CBD-based therapeutic for acute